Skip to main content
Hit enter to search or ESC to close
Close Search
search
Menu
About us
Team
Companies
Stories
ESG
News
Contact
Investors
Keensight Connect
search
Press Release
Keensight Capital invests in Biovian, a leading biopharmaceutical contract development and manufacturing organization (CDmO)
By
WeAreBlow
May 23, 2018
February 1st, 2019
No Comments
Download
Télécharger
Previous Post
Theodor Wuppermann joins Keensight Capital as Associate Director
Next Post
PIXID continues European expansion with acquisition of Dutch staffing CRM supplier Carerix
Close Menu
About us
Team
Companies
Stories
ESG
News
Contact
Investors
Keensight Connect
linkedin
© 2023 – Keensight Capital. All rights reserved.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
OK
Terms & conditions
